Interferon gamma biosimilar (Center for Genetic Engineering and Biotechnology)

干扰素γ生物类似药 (Center for Genetic Engineering and Biotechnology)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon gamma biosimilar (Center for Genetic Engineering and Biotechnology)
Drug Alias Name干扰素γ生物仿制药 (Center for Genetic Engineering and Biotechnology)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon gamma receptor stimulants
TargetsInterferon gamma receptor
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesCenter For Genetic Engineering And Biotechnology
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeL03AB03
Related LinksN/A